Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231

Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231

Objective: We aimed to evaluate the therapeutic effects of paclitaxel in combination with mTOR inhibitor everolimus on adriamycin-resistant breast cancer cell line MDA-MB-231 (MDA-MB-231/ADR). Materials and methods: MDA-MB-231/ADR cells were treated with different concentrations of paclitaxel and ev...

Full description

Bibliographic Details
Main Authors: Tinghua Xu, Pengxi Liu, Qingming Li, Changbin Shi, Xinjie Wang
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Taiwanese Journal of Obstetrics & Gynecology
Subjects:
Adriamycin
Breast cancer
Everolimus
Paclitaxel
Resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S1028455920302199

Internet

http://www.sciencedirect.com/science/article/pii/S1028455920302199

Similar Items